A fat-fighting jab known as the 'King Kong' weight loss drugs could soon be coming to the UK and US - with some able to shed 100 pounds in just a few months.
As a growing number of overweight Americans clamor for Ozempic and Wegovy - drugs touted by celebrities and on TikTok to shed pounds - the even more powerful obesity medicine is poised to upend treatment.
Tirzepatide, an Eli Lilly and Co. drug approved to treat type 2 diabetes under the brand name Mounjaro, helped people with the disease who were overweight or had obesity lose up to 16 per cent of their body weight, or more than 34 pounds, over nearly 17 months, the company said on Thursday.
